Boeing Commercial Exec Stan Deal Says Demand Has Bounced Back Dramatically, The Challenge Has Been The Supply Chain

Key Takeaways: Vivere Lifesciences Acquisition Corp., whose co-founders include U.S.-listed I-Mab, could become the first Hong Kong SPAC backed by a U.S.-listed Chinese company The SPAC is targeting Chinese or multinational companies with Chinese operations in the health sector By Fai Pui